Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg
Ibuprofen and Famotidine tablets approved by FDA
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
PendraCare Group develops, manufactures and sells innovative cardiology catheter solutions and provides design, development and manufacturing services to other global OEM’s
Subscribe To Our Newsletter & Stay Updated
